UB’s Clinical and Translational Science Institute (CTSI) launched its Dissemination and Implementation Science Core in 2025. Starting Feb. 9, the core will offer a new Dissemination and Implementation ...
The Patient-Centered Outcomes Research Institute (PCORI) today announced new funding to support patient-centered comparative ...
Hosted on MSN
Bringing evidence to everyday patient care
From brain cancer biopsies to AI in mental health, healthcare teams are finding new ways to connect research with real-world treatment. Evidence-based practice blends science, clinical expertise, and ...
To bring novel precision evidence to existing workflows, the company said its growing medical library is accessible through ...
In today's ACT Brief, we examine Thermo Fisher's expanded real-world data access through HealthVerity, how FHIR-based ...
The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.
Data from the CLARITY study will provide insights on acceptability and tolerability of single-dose cabotegravir and lenacapavir long-acting injections Four-year analysis from the OPERA cohort examines ...
The first biosimilars referencing Humira became available in 2023. That year, 10 FDA-approved adalimumab are now on the ...
A research team led by Dr. Sun Xin (孙鑫) and Prof. Tan Jing (谭婧) from the Clinical Epidemiology and Evidence-based Medicine Center, West China Hospital, Sichuan University, recently published an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results